Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for DIPYRIDAMOLE
- Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
- Brequinar Combined With Dipyridamole in Patients With Mild to Moderate SARS-CoV-2 Infection.
- Apixaban, Warfarin and Aspirin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy（ESAWAAPT）
- RepurpoSing Old Drugs TO SuppRess a Modern Threat: COVID-19 STORM
- Trial of Open Label Dipyridamole- In Hospitalized Patients With COVID-19
- Aggrenox To Treat Acute Covid-19
- Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
- Dipyridamole to Prevent Coronavirus Exacerbation of Respiratory Status (DICER) in COVID-19
- Effects of Ranolazine on Coronary Microvascular Dysfunction in Patients With Hypertrophic Cardiomyopathy
- Study on Children Henoch-Schönlein Purpura Nephritis With TCM Multistep Treatment
- REstart or STop Antithrombotic Randomised Trial in France
- Assessment of the Efficacy of Ocular Dipyridamole in the Treatment of Dry Eye Symptomology in Subjects With Pterygium
- Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization
- Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis
- Apixaban After Anticoagulation-associated Intracerebral Haemorrhage in Patients With Atrial Fibrillation
- Analysis of Adenosine on Sinus and Atrioventricular Nodal Conduction in the Pediatric Transplanted Heart
- Study to Compare the Effect of a Combination of Dipyridamole With Sustained Release and Acetyl Salicylic Acid (Aggrenox®) on the Performance Relevant to Safety and on the General Condition of Healthy Volunteers
- Bioavailability of Dipyridamole of Asasantin p.o. in Three Experimental Formulations Relative to the Standard Formulation in Healthy Male Subjects
- Study to Evaluate Pharmacokinetics of Dipyridamole in Three New Formulations of Asasantin ER in Healthy Female and Male Subjects
- Bioequivalence of a New Asasantin Formulation Extended Release (ER) Compared to the Commercially Available Asasantin Formulation (Aggrenox®; Extended Release) in Healthy Male and Female Volunteers
- Study to Compare the Pharmacokinetics of Dipyridamole in Three Different Asasantin Extended Release (ER) Formulations in Healthy Male and Female Volunteers
- Comparison of Pharmacokinetics of Dipyridamole in Asasantin Extended Release (ER) and in a Combination of Persantin Immediate Release Tablets and ASA Tablets in Healthy Subjects
- Tolerability of Asasantin in Healthy Female and Male Subjects
- Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers
- Relative Bioavailability of Telmisartan and Dipyridamole After Co-administration Compared to the Bioavailability of Telmisartan or Dipyridamole Alone in Healthy Female and Male Subjects
- Pharmacokinetics of Dipyridamole Administered as Aggrenox® (Dipyridamole Extended Release Plus Aspirin) Capsule Versus Dipyridamole Immediate Release Plus Aspirin Following Alteration of Stomach pH
- Warfarin Prevents Portal Vein Thrombosis in Patients After Laparoscopic Splenectomy and Azygoportal Disconnection
- Warfarin Prevents Portal Vein Thrombosis in Liver Cirrhotic Patients With Hypersplenism After Laparoscopic Splenectomy
- Mechanism of Dipyridamole Action in Platelets: in Vivo Study With Healthy Volunteers
- Dipyridamole for Immune Activation in HIV
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Eplerenone and Extracellular Adenosine Formation
- Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)
- Effect of Ticagrelor vs. Dipyridamole on Adenosine Uptake
- Triple Antiplatelets for Reducing Dependency After Ischaemic Stroke
- Metformin-Dipyridamole Interaction Trial
- Long Term Safety Trial of z102 and Prednisone in Patients With Moderate to Severe Rheumatoid Arthritis
- Phase II Study for the Diagnosis and Functional Assessment of CAD Using Transthoracic-Echodoppler
- Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.
- A Phase II Trial Comparing Z-102 With Placebo In Patients With Moderate To Severe Rheumatoid Arthritis
- Drug-drug Interaction Study of Aggrenox and Omeprazole in Normal Volunteers
- Can Dipyridamole Induce Protection Against Ischemia and Reperfusion Injury in Patients Undergoing Elective Coronary Artery Bypass Grafting (CABG)?
- Adenosine Activity in Producing Venoarteriolar Reflexes
- The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia
- Regadenoson Combined With Symptom-Limited Exercise in Patients Undergoing Myocardial Perfusion Imaging
- "Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-up
- The Vascular Biology of Dipyridamole in Peripheral Arterial Disease (PAD)
- Multivariable Assessment of Coronary Artery Disease Using Cardiac CT Imaging
- Lexiscan(TM) Rb-82 Myocardial Perfusion PET: A Comparison With Dipyridamole Stress
- Persantin Preceding Elective PCI
- Persantine: Variation in Response Trial
- GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients
- EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA
- Efficacy of Allopurinol and Dypiridamole in Acute Mania
- The Effect of Rosuvastatin on Adenosine Metabolism
- Multicenter Study to Evaluate CRx-102 vs. Each of Its Components to Treat Active Rheumatoid Arthritis
- CRx-102 Osteoarthritis Multicenter Evaluation Trial
- Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
- Does Caffeine Reduce Dipyridamole-Induced Protection Against Ischemia-Reperfusion Injury?
- Clinical Trial of Dipyridamole in Schizophrenia
- JASAP: Japanese Aggrenox Stroke Prevention vs. Aspirin Programme
- Dipyridamole/Magnesium To Improve Sickle Cell Hydration
- Pilot Study of Rituximab for Membranoproliferative Glomerulonephritis
- Headache Study to Compare Aggrenox Full Dose and Reduced Dose
- Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole
- To Determine the Feasibility of a Clinical Trial Comparing Anticoagulants Versus Antiplatelets in the Acute Treatment of Patients With Cervical Artery Dissection
- Treatment of Supine Hypertension in Autonomic Failure
- Aspirin for the Prevention of Recurrent Venous Thromboembolism
- The Influence of Methotrexate on the Metabolism and Vascular Effects of Adenosine in Humans
- ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
- PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
- Modified-release Dipyridamole/Aspirin (200mg/25mg bd) Versus Aspirin (75mg) in Aspirin-resistant Patients
- Aggrenox Prevention of Access Stenosis
- S9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic Cancer
- Methotrexate Plus Dipyridamole in Treating Patients With Advanced Ovarian Cancer
- Recurrent Carotid Stenosis
- Platelet-Inhibitor Drug Trial in Coronary Angioplasty
- Platelet Drug Trial in Coronary Disease Progression
- Post Coronary Artery Bypass Graft (CABG) Study
Clinical trials list
click for details